“How does the FDA regard signage or billboards advertising pharmaceutical products that are prominently displayed at ballparks and other sports stadiums, and which may be viewed by tens of thousands or even millions of sports fans at televised events? Does such signage come under FDA’s authority … ?”
This intriguing question from the audience seemed to stump a panel of FDA staffers at the DTC National Conference in Washington in April.
After a pause, Division of Drug Marketing, Advertising, and Communications reviewer Kathryn Aikin spoke for the panel: “Honestly, I don’t know the answer to that question. I’m not sure we’ve ever thought about it. But we’ll discuss it back at the office.”
From the June 01, 2006 Issue of MM+M - Medical Marketing and Media
